Trial intelligence / Profile preview

Hydrogen peroxide gargle and nasal spray as adjunctive treatment for COVID-19

RBR-6sx3szPhase 2Terminated

Sponsor
Programa de Pós-Graduação em Odontologia da Universidade de Passo Fundo
Start
Jun 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of hydrogen peroxide in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Programa de Pós-Graduação em Odontologia da Universidade de Passo Fundo. Started Jun 2020; status: terminated.

02

Drugs

hydrogen peroxide
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on RBR-6sx3sz.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-6sx3sz.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call